| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.9 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | -0.023 | 0.9 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |